See more : Deceuninck NV (DECB.BR) Income Statement Analysis – Financial Results
Complete financial analysis of Acadia Healthcare Company, Inc. (ACHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Acadia Healthcare Company, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- New Pacific Metals Corp. (NUAG.TO) Income Statement Analysis – Financial Results
- Dyna-Mac Holdings Ltd. (NO4.SI) Income Statement Analysis – Financial Results
- Robex Resources Inc. (RBX.V) Income Statement Analysis – Financial Results
- Careplus Group Berhad (0163.KL) Income Statement Analysis – Financial Results
- LL Lucky Games AB (publ) (LADYLU.ST) Income Statement Analysis – Financial Results
Acadia Healthcare Company, Inc. (ACHC)
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.93B | 2.61B | 2.31B | 2.09B | 3.11B | 3.01B | 2.84B | 2.81B | 1.79B | 1.00B | 713.41M | 407.46M | 221.37M | 62.10M |
Cost of Revenue | 2.25B | 1.49B | 1.33B | 1.24B | 1.84B | 1.78B | 1.65B | 1.66B | 1.05B | 623.83M | 445.53M | 259.14M | 167.94M | 42.36M |
Gross Profit | 682.61M | 1.12B | 979.89M | 848.17M | 1.27B | 1.23B | 1.19B | 1.15B | 740.10M | 380.77M | 267.88M | 148.33M | 53.44M | 19.74M |
Gross Profit Ratio | 23.31% | 42.78% | 42.34% | 40.58% | 40.78% | 40.96% | 41.80% | 40.97% | 41.24% | 37.90% | 37.55% | 36.40% | 24.14% | 31.79% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 176.01M | 203.48M | 175.26M | 157.85M | 323.21M | 307.71M | 273.00M | 258.83M | 148.99M | 64.68M | 47.22M | 26.86M | 57.74M | 3.08M |
Other Expenses | 0.00 | 445.60M | 390.16M | 357.53M | 539.48M | -34.51M | -24.27M | -48.32M | -36.57M | -13.65M | -7.15M | -8.11M | 24.76M | -918.00K |
Operating Expenses | 176.01M | 649.07M | 565.41M | 515.38M | 862.69M | 821.04M | 747.84M | 706.49M | 419.29M | 208.00M | 144.88M | 77.62M | 82.50M | 10.93M |
Cost & Expenses | 2.42B | 2.14B | 1.90B | 1.76B | 2.70B | 2.60B | 2.40B | 2.37B | 1.47B | 831.84M | 590.41M | 336.75M | 250.44M | 53.29M |
Interest Income | 0.00 | 69.76M | 76.99M | 158.11M | 187.33M | 876.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 82.13M | 69.76M | 76.99M | 158.11M | 187.09M | 185.41M | 176.01M | 181.33M | 106.74M | 48.22M | 37.25M | 29.77M | 9.19M | 738.00K |
Depreciation & Amortization | 132.35M | 117.77M | 106.72M | 95.26M | 87.92M | 158.83M | 143.01M | 135.10M | 63.55M | 32.67M | 17.09M | 7.98M | 4.29M | 976.00K |
EBITDA | 189.11M | 561.67M | 459.47M | 437.16M | 402.02M | 385.88M | 580.89M | 580.25M | 384.36M | 205.43M | 140.09M | 70.58M | -24.78M | 8.87M |
EBITDA Ratio | 6.46% | 21.52% | 22.52% | 22.05% | 18.30% | 18.97% | 20.48% | 20.64% | 21.42% | 20.45% | 19.64% | 19.31% | -11.19% | 14.29% |
Operating Income | 506.60M | 443.90M | 414.47M | 365.61M | 404.53M | 412.74M | 437.88M | 445.14M | 320.81M | 172.76M | 123.00M | 70.71M | -29.07M | 8.81M |
Operating Income Ratio | 17.30% | 17.01% | 17.91% | 17.49% | 13.02% | 13.70% | 15.44% | 15.84% | 17.88% | 17.20% | 17.24% | 17.35% | -13.13% | 14.19% |
Total Other Income/Expenses | -531.96M | -72.10M | -120.81M | -148.99M | -235.70M | -581.70M | -201.08M | -412.19M | -156.06M | -46.61M | -53.75M | -37.88M | -5.38M | -1.66M |
Income Before Tax | -25.36M | 374.14M | 275.76M | 183.80M | 135.99M | -168.95M | 236.80M | 32.96M | 164.75M | 126.15M | 69.25M | 32.83M | -38.26M | 7.16M |
Income Before Tax Ratio | -0.87% | 14.33% | 11.91% | 8.79% | 4.38% | -5.61% | 8.35% | 1.17% | 9.18% | 12.56% | 9.71% | 8.06% | -17.28% | 11.53% |
Income Tax Expense | -9.70M | 94.11M | 67.56M | 40.61M | 25.87M | 6.53M | 37.21M | 28.78M | 46.40M | 42.92M | 25.98M | 12.33M | -5.38M | 477.00K |
Net Income | -21.67M | 273.14M | 190.64M | 143.19M | 108.92M | -175.75M | 199.84M | 6.14M | 119.55M | 83.04M | 42.58M | 20.40M | -34.89M | 6.21M |
Net Income Ratio | -0.74% | 10.46% | 8.24% | 6.85% | 3.51% | -5.83% | 7.05% | 0.22% | 6.66% | 8.27% | 5.97% | 5.01% | -15.76% | 10.00% |
EPS | -0.24 | 3.05 | 2.30 | 1.63 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.51 | 0.85 | 0.53 | -1.86 | 0.35 |
EPS Diluted | -0.24 | 2.98 | 2.25 | 1.62 | 1.24 | -2.01 | 2.30 | 0.07 | 1.75 | 1.50 | 0.85 | 0.53 | -1.86 | 0.35 |
Weighted Avg Shares Out | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.70M | 68.09M | 55.06M | 50.00M | 38.48M | 18.76M | 17.63M |
Weighted Avg Shares Out (Dil) | 90.95M | 91.56M | 90.79M | 88.60M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.70M | 18.76M | 17.63M |
ACHC Investors Have Opportunity to Lead Acadia Healthcare Company, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
Acadia Healthcare Company, Inc. Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Join The Schall Law Firm
Acadia Healthcare (ACHC) Faces Investor Lawsuit Over Allegations of Patient Mistreatment - Hagens Berman
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Acadia Healthcare Company, Inc. - ACHC
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
ACHC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare
ACHC Investors Have Opportunity to Lead Acadia Healthcare Company Inc. Securities Fraud Lawsuit
ACHC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Acadia Healthcare Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Source: https://incomestatements.info
Category: Stock Reports